Table 1.
The effect of Lsh deletion on splenic subpopulations
Control | −/− | |
---|---|---|
0 | Total spleen, % | Total spleen, % |
CD3+ | 30.4 ± 12 | 40.5 ± 18 (133%)* |
B220+ IgM+ | 43.1 ± 11 | 20.6 ± 7.8 (48% P < 0.0001) |
CD4+ | 15.5 ± 3.5 | 16.6 ± 10.2 (107%) |
CD8+ | 7.7 ± 2.2 | 14.9 ± 7.3 (193% P < 0.01) |
Mac1+ | 4.1 ± 0.9 | 6.8 ± 1.8 |
Mac1+GR1+ | 5.8 ± 1.6 | 20.7 ± 8.3 |
Fetal liver cell suspensions of Lsh−/− and +/+ embryos were injected into Rag-2−/− recipients, and spleens were harvested after 5 wk. Splenocytes were analyzed by FACS for expression of T cell surface markers CD3, CD4, and CD8, or B cell surface markers B220 and IgM. Values represent percentage positive FACS stain of total spleen population and SD. Average numbers summarize four individual experiments with Lsh−/− (n = 11) and control (n = 19). Percentage difference in comparison with control and statistically relevant P values are indicated in parentheses.
Indicates percentage change in comparison to control value that is set as 100%.